Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Chou

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Blood Cancer Journal|March 21, 2015
Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysisK-H Lim, Y-C Chang, C Gon-Shen Chen, et al.
Blood Cancer Journal|July 29, 2017
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemiaH-A Hou, J-W Lu, T-Y Lin, et al.
Leukemia|October 14, 2014
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDSD Inoue, J Kitaura, H Matsui, et al.
Leukemia|February 20, 2009
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patientsW-C Chou, C-Y Chen, H-A Hou, et al.
British Journal of Cancer|September 1, 2011
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromesC-L Cheng, H-A Hou, J-Y Jhuang, et al.
Physical Chemistry Chemical Physics : PCCP|February 6, 2013
Efficient energy transfer from InGaN quantum wells to Ag nanoparticlesG W Shu, C H Chiu, L T Huang, et al.
ESMO Open|November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysisG Trovato, D Rossini, A Guidolin, et al.
Leukemia|November 17, 2010
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemiaW-C Chou, W-C Lei, B-S Ko, et al.
Blood Cancer Journal|August 1, 2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolutionH-A Hou, W-C Chou, Y-Y Kuo, et al.
Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Blood Cancer Journal|March 21, 2015
Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysisK-H Lim, Y-C Chang, C Gon-Shen Chen, et al.
Blood Cancer Journal|July 29, 2017
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemiaH-A Hou, J-W Lu, T-Y Lin, et al.
Leukemia|October 14, 2014
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDSD Inoue, J Kitaura, H Matsui, et al.
Leukemia|February 20, 2009
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patientsW-C Chou, C-Y Chen, H-A Hou, et al.
British Journal of Cancer|September 1, 2011
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromesC-L Cheng, H-A Hou, J-Y Jhuang, et al.
Physical Chemistry Chemical Physics : PCCP|February 6, 2013
Efficient energy transfer from InGaN quantum wells to Ag nanoparticlesG W Shu, C H Chiu, L T Huang, et al.
ESMO Open|November 8, 2025
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine-nab-paclitaxel failure: a propensity score-matched analysisG Trovato, D Rossini, A Guidolin, et al.
Leukemia|November 17, 2010
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemiaW-C Chou, W-C Lei, B-S Ko, et al.
Blood Cancer Journal|August 1, 2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolutionH-A Hou, W-C Chou, Y-Y Kuo, et al.
Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.
Pageof 6